Market Closed -
Nasdaq Stockholm
11:29:38 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
0.2365
SEK
|
+3.05%
|
|
-2.07%
|
-18.45%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
110.3
|
16.31
|
15.23
|
25.67
|
340.9
|
117.8
|
Enterprise Value (EV)
1 |
90.78
|
1.401
|
15.67
|
22.25
|
322.3
|
107.3
|
P/E ratio
|
-3.05
x
|
-0.63
x
|
-1.32
x
|
-2.05
x
|
-18.6
x
|
-7.44
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
12.5
x
|
2.52
x
|
1.2
x
|
13
x
|
3,343
x
|
81.6
x
|
EV / Revenue
|
10.3
x
|
0.22
x
|
1.23
x
|
11.3
x
|
3,160
x
|
74.3
x
|
EV / EBITDA
|
-3.34
x
|
-0.05
x
|
-1.37
x
|
-2.65
x
|
-20.8
x
|
-6.98
x
|
EV / FCF
|
-4.12
x
|
-
|
-
|
-
|
-27.9
x
|
-9.16
x
|
FCF Yield
|
-24.3%
|
-
|
-
|
-
|
-3.58%
|
-10.9%
|
Price to Book
|
5.71
x
|
2.09
x
|
2.71
x
|
3.39
x
|
12.4
x
|
4.86
x
|
Nbr of stocks (in thousands)
|
13,873
|
13,885
|
27,784
|
83,353
|
147,583
|
159,367
|
Reference price
2 |
7.950
|
1.175
|
0.5480
|
0.3080
|
2.310
|
0.7390
|
Announcement Date
|
4/27/18
|
4/26/19
|
4/24/20
|
4/26/21
|
3/23/22
|
4/21/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
8.788
|
6.48
|
12.69
|
1.978
|
0.102
|
1.443
|
EBITDA
1 |
-27.19
|
-29.27
|
-11.44
|
-8.408
|
-15.53
|
-15.37
|
EBIT
1 |
-28.83
|
-29.62
|
-11.65
|
-8.666
|
-15.74
|
-15.66
|
Operating Margin
|
-328.07%
|
-457.06%
|
-91.78%
|
-438.18%
|
-15,433.68%
|
-1,084.93%
|
Earnings before Tax (EBT)
1 |
-29.01
|
-27.5
|
-11.49
|
-9.035
|
-16.21
|
-15.53
|
Net income
1 |
-29.01
|
-27.5
|
-11.49
|
-9.035
|
-16.21
|
-15.53
|
Net margin
|
-330.16%
|
-424.3%
|
-90.56%
|
-456.82%
|
-15,889.67%
|
-1,076.1%
|
EPS
2 |
-2.610
|
-1.860
|
-0.4138
|
-0.1505
|
-0.1244
|
-0.0993
|
Free Cash Flow
1 |
-22.03
|
-
|
-
|
-
|
-11.53
|
-11.72
|
FCF margin
|
-250.67%
|
-
|
-
|
-
|
-11,310.22%
|
-811.79%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/27/18
|
4/26/19
|
4/24/20
|
4/26/21
|
3/23/22
|
4/21/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
0.44
|
-
|
-
|
-
|
Net Cash position
1 |
19.5
|
14.9
|
-
|
3.42
|
18.6
|
10.5
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.0387
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-22
|
-
|
-
|
-
|
-11.5
|
-11.7
|
ROE (net income / shareholders' equity)
|
-181%
|
-157%
|
-108%
|
-116%
|
-86.3%
|
-59.9%
|
ROA (Net income/ Total Assets)
|
-57.9%
|
-62.7%
|
-39.6%
|
-49.3%
|
-47.4%
|
-34.4%
|
Assets
1 |
50.09
|
43.85
|
29.03
|
18.33
|
34.19
|
45.2
|
Book Value Per Share
2 |
1.390
|
0.5600
|
0.2000
|
0.0900
|
0.1900
|
0.1500
|
Cash Flow per Share
2 |
1.420
|
0.5400
|
0.0600
|
0.0300
|
0.1300
|
0.0700
|
Capex
1 |
0.88
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
9.96%
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/27/18
|
4/26/19
|
4/24/20
|
4/26/21
|
3/23/22
|
4/21/23
|
|
1st Jan change
|
Capi.
|
---|
| -18.45% | 5.41M | | +6.56% | 32.91B | | +17.38% | 8.1B | | -2.71% | 6.98B | | +20.18% | 5.45B | | -3.97% | 4.13B | | +34.04% | 3.95B | | +5.47% | 3.4B | | -9.99% | 2.72B | | +8.20% | 2.43B |
Testing & Measuring Equipment
|